Rezultati pretraživanja
  1. . Vision Care Opportunities Cork (updated 3rd February) 38538 QA Specialist (Validation/Audit) 39421 QA Specialist (Batch Record Review) 39475 Regulatory Compliance Specialist All Details > NO VISA PROCESSING

  2. Last week, initiated a Phase 2a study in collaboration with (not rated), evaluating the combination of ZW25 with palbociclib plus fulvestrant in HER2-positive patients.

  3. Preclinical Study Shows rhNELL-1 Effectively Promotes Bone Formation

  4. prije 2 sata

    Join Dr. Rose Hughes, European Patent Attorney for and Dr. Caroline Peel, Head of & Standards Content at as they discuss trends & the importance of biologic drugs:

  5. prije 5 sati

    Due to the complexity of a comprehensive set of quantitative, accurate and precise tools are required. We've a broad portfolio of functional and protein characterisation tools for your drug discovery work. More at

  6. prije 11 sati

    Kemwell Vision is to be a global leader and first-choice CDMO for biologics. . .

  7. 31. sij

    VIRAL SAFETY BY DESIGN FOR CELL AND GENE THERAPY PRODUCTS Together with product , product safety is an essential characteristic of any medicinal product including cell and gene therapy (C&GT) . age…

  8. Our latest Reprint - Get your own print copy - send Email at marketing@protagenproteinservices.com "Mass spectrometric evaluation of upstream and downstream process influences on host cell protein patterns in biopharmaceutical products"

  9. 30. sij

    did not set any records last year in approving new and for market, but it did speed a number of important new to patients. More details here:

  10. 30. sij

    One year ago, the FDA released the Biosimilars Action Plan outlining steps to promote innovation and competition among and enhance development of . View the report card to see the status of key initiatives laid out in the plan:

  11. German company Merck KGaA is investing Euro 250 million in a Swiss facility that bridges manufacturing and research:

  12. 30. sij
  13. 29. sij

    is the focal point today for one of the world’s most successful Pharma cos. Yesterday opened a new facility there. To say has become Westport’s biggest employer barely hints at its true impact on the town -

  14. 29. sij
  15. 28. sij
  16. 28. sij

    MCRA Strengthens Its Reimbursement, Health Economics, and Market Access Division with the Hiring of John D. McDermott, Jr., MBA. Full release:

  17. 28. sij

    Compared to small molecules, are harder to manufacture, keep and administer. Learn how packaging, and play a key role in biologics drug delivery with Yasemin Karanis', IQVIA Thought Leadership, latest article.

  18. 28. sij

    Cell-based are inherently complex & variable. Download this article describing new approaches to bioassay design that lead to more comprehensive characterisation of :

  19. 27. sij

    Assortment of items that incorporate antibodies, immunizations, blood segments, blood, tissues, remedial proteins, substantial and allergenic cells are available in . For an assortment of other significant purposes. Learn More:-

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.